Edward B Dugas, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 70 Kenyon Ave Unit 324, Wakefield, RI 02879 Phone: 401-782-1199 Fax: 401-782-1120 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it (and its subsidiary Par Pharmaceutical and development partner MN Pharmaceuticals of Turkey) has entered into a settlement agreement with sanofi-aventis that resolves patent litigation related to its generic version of sanofi's and Debiopharm's Eloxatin® (oxaliplatin injection) product, a drug used to treat colorectal cancer, in the U.S. District Court for the District of New Jersey.
Scientists from two universities in Italy and Virginia Tech in the United States have determined the structure of a protein that is responsible for the production xanthurenic acid (XA) in Anopheles gambiae, the malaria carrying mosquitoes.
TSO3 Inc. ("TSO3") (TSX: TOS), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that discussions with 3M continue, with the intent of signing a definitive agreement which would provide 3M with a global license and distribution rights to TSO3's STERIZONE 125L sterilizer including new cycles recently announced by TSO3.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
Scratching the skin triggers a series of immune responses culminating in an increased number of activated mast cells-immune cells involved in allergic reactions-in the small intestine, according to research conducted in mice.
› Verified 2 days ago